Biohaven Pharmaceutical Holding Company Ltd

NYSE:BHVN   3:59:58 PM EDT
77.42
-1.05 (-1.34%)
Products

Biohaven Says U.S. FDA Accepts Supplemental New Drug Application Of NURTEC ODT

Published: 10/14/2020 11:42 GMT
Biohaven Pharmaceutical Holding Company Ltd (BHVN) - U.S. FDA Accepts Biohaven's Supplemental New Drug Application (snda) of Nurtec™ Odt for the Preventive Treatment of Migraine.
Biohaven Pharmaceutical - Prescription Drug User Fee Act Goal Date for Completion of FDA Review of Preventive Snda is Set for 2q2021.